WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,850.00
-160.00 (-7.96%)
Last updated: Jun 26, 2025

WOOJUNG BIO Revenue

WOOJUNG BIO had revenue of 8.31B KRW in the quarter ending March 31, 2025, a decrease of -18.16%. This brings the company's revenue in the last twelve months to 41.36B, up 1.69% year-over-year. In the year 2024, WOOJUNG BIO had annual revenue of 43.20B with 11.87% growth.

Revenue (ttm)
41.36B
Revenue Growth
+1.69%
P/S Ratio
0.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
32.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202443.20B4.58B11.87%
Dec 31, 202338.62B-8.30B-17.70%
Dec 31, 202246.92B15.68B50.20%
Dec 31, 202131.24B-6.11B-16.35%
Dec 31, 202037.34B5.05B15.65%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
Samsung Biologics 4,898.69B
LG Energy Solution 25.76T
Hyundai Motor Company 178.98T
Doosan Enerbility 15.88T
Hanwha Aerospace 15.28T
KB Financial Group 14.93T
Revenue Rankings